Enanta Pharmaceuticals
ENTA
#8003
Rank
C$0.27 B
Marketcap
$13.02
Share price
2.53%
Change (1 day)
-4.70%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2024 (TTM): -C$0.15 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$71.96 Million. In 2023 the company made an earning of -C$0.18 Billion a decrease over its 2022 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.15 Billion-19.2%
2023 -C$0.18 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.18 Billion91.12%
2020 -C$93.42 Million-407.13%
2019 C$30.41 M-78.63%
2018 C$0.14 B117.97%
2017 C$65.3 M-574.65%
2016 -C$13.76 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$24.71 Million-137.98%
2012 C$65.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.88 B-6,727.96%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.72 B-17,354.64%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.35 B-340.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.05 B-15,567.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.63 Billion 6,353.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.80 B-12,042.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland